FDA Drug Application (022239) for SUMAVEL DOSEPRO by ENDO VENTURES LTD

Back to FDA Applications sponsored by ENDO VENTURES LTD

Application Number022239
Product Number001
FormINJECTABLE;SUBCUTANEOUS
DosageEQ 6MG BASE/0.5ML (EQ 12MG BASE/ML)
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code BX Drug products for which the data are insufficient to determine therapeutic equivalence
Reference Drug
Drug NameSUMAVEL DOSEPRO
Active IngredientSUMATRIPTAN SUCCINATE

Active IngredientCount
List of drugs with Active Ingredient SUMATRIPTAN SUCCINATE10


Back to FDA Applications sponsored by ENDO VENTURES LTD